Statistics
Publications
7
Citations
1K
H-Index
7
Active since
2004
Richard Gregory is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and life sciences.
Publications per year
2004–2022
7
7
BET inhibitor resistance emerges from leukaemia stem cells
Chun Yew Fong, Omer Gilan, Enid Y.N. Lam et al. · Nature · 2015 · 548 citations · Full text
Medicine, Cancer Biology, Oncology +14
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
Bingyu Yan, Tilo Freiwald, Daniel Chauss et al. · Science Immunology · 2021 · 203 citations · Full text
Click chemistry enables preclinical evaluation of targeted epigenetic therapies
Dean Tyler, Johanna Vappiani, Tatiana Cañeque et al. · Science · 2017 · 143 citations · Full text
Medicine, Oncology, Pharmacology +17
Parallelising a model of bacterial interaction and evolution
Richard Gregory, Ray Paton, J. R. Saunders et al. · Biosystems · 2004 · 22 citations
Life Sciences, Biology, Microbiology +12
1–5 of 7